发明名称 |
Nitroxyl Progenitors in the Treatment of Heart Failure |
摘要 |
Administration of an HNO/NO− donating compound, such as Angeli's salt, increases myocardial contractility while concomitantly lowering left ventricular preload in subjects experiencing heart failure. Moreover, administration of the HNO/NO− donating compound isopropylamine (IPA)/NO (Na(CH3)2CHNHN(O)NO) surprisingly exhibited positive inotropic effects in subjects experiencing heart failure that were superior to those caused by the HNO/NO− donating compound Angeli's salt. Additionally, in contrast to the effects observed with NO− donors, administration of an HNO/NO− donor in combination with a positive inotropic agent did not impair the positive inotropic effect of the positive inotropic agent. Further, HNO/NO− exerts its positive inotropic effect independent of the adrenergic system, increasing contractility even in subjects receiving beta-antagonist therapy.
|
申请公布号 |
US2011081427(A1) |
申请公布日期 |
2011.04.07 |
申请号 |
US20100949533 |
申请日期 |
2010.11.18 |
申请人 |
THE GOVERNMENT OF THE U.S.A. AS REPRESENTED BY THE SECRETARY OF THE DEPT. OF HEALTH AND HUMAN SERVIC;THE BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE;THE REGENTS OF THE UNIVERSITY OF CALIFORNIA;JOHNS HOPKINS UNIVERSITY |
发明人 |
WINK DAVID A.;FEELISCH MARTIN;KASS DAVID A.;PAOLOCCI NAZARENO;MIRANDA KATRINA;FUKUTO JON;KATORI TATSUO |
分类号 |
A61K33/00;A61K31/13;A61K31/16;A61K31/655;A61P9/04 |
主分类号 |
A61K33/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|